Wu J, Perez A, Sullivan PW
Notable safety advantages : Lower discontinuation rates due to adverse events (4-7%) compared to reported rates with semaglutide 2.4 mg in STEP trials (approximately 6-7%) No signal for diabetic retinopathy worsening (a concern identified with semaglutide in SUSTAIN-6) No evidence of increased psychiatric adverse events (depression, suicidality) Research Applications Tirzepatide serves as a groundbreaking research tool across multiple biomedical domains: Dual incretin biology : Studying the synergistic effects of simultaneous GIP and GLP-1 receptor activation on glucose homeostasis, appetite, and metabolism Adipose tissue biology : Investigating GIPR-mediated effects on adipocyte differentiation, lipid buffering, and adipokine secretion mechanisms absent from GLP-1 agonist research Central appetite neuroscience : Mapping distinct GIP vs

SeekPeptides members access detailed vendor analyses, dosing protocols, safety databases, and community insights that help navigate these complex sourcing decisions
However, hair loss is now a recognised emerging signal across this whole class of weight-loss drugs
While a drink now and then may be fine, mixing the two regularly can create challenges for your health and your goals